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Purpose: This study examines within-family differences in the uptake of the HPV vaccine and HPV-
related beliefs by children's sex.
Methods: From a 2011–2013 survey of mothers of children aged 9–17 years in Texas, mothers with both
male and female children (n¼350) were selected.
Results: Mothers were more likely to report having initiated and completed HPV vaccination for their
daughters than sons. Mothers did not express differences by children's sex in HPV-related beliefs. Among
those who had not completely vaccinated either child, mothers were more likely to report they wanted
their daughters compared to sons vaccinated and were more likely to report feeling conﬁdent they could
get their daughters vaccinated than their sons.
Conclusion: In this population, mothers were more likely to report HPV vaccination of and motivation to
vaccinate daughters compared to sons, although maternal beliefs about HPV did not differ by
children's sex.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The human papillomavirus (HPV) is responsible for approxi-
mately 18,000 cancers among females and 8000 cancers among
males per year in the United States [1]. HPV vaccination has the
potential to prevent the majority of HPV-related cancers and
genital warts. While the Advisory Committee on Immunization
Practices recommends that males and females receive routine HPV
vaccination beginning at 11 or 12 years of age [2], recent estimates
from the National Immunization Survey – Teen of the receipt of
Z1 dose were 60.0% in adolescent females and 41.7% in adolescent
males [3]. Thus far, interventions aiming to increase HPV vacci-
nation, have had limited success, with mixed results found in two
recent reviews [4,5].
Studies have identiﬁed differences in barriers to HPV vaccina-
tion of sons compared to daughters, including differences in pro-
vider recommendation, concerns about safety, and parents not
knowing that boys could get the vaccine [6]. Though studies have
examined within-family differences in HPV vaccination intention
by children's sex [7], no studies have reported on within-family
differences in HPV-related beliefs by children's sex. The aim of thisB.V. This is an open access article u
þ1 409 747 5129.
n).study was to examine within-family differences by children's sex
in HPV vaccine uptake and HPV-related beliefs.2. Methods
Between September 2011 and October 2013, women with Z1
child aged 9–17 years were identiﬁed through review of the daily
census and approached at four reproductive health clinics oper-
ated by the University of Texas Medical Branch (UTMB) to parti-
cipate in a survey on HPV vaccination. Eligible participants were
invited to complete a self-administered survey, available in either
English or Spanish, and were reimbursed $5 for their time and
effort. The UTMB Institutional Review Board approved this study.
Of the 1436 women who met eligibility criteria, 1392 (97%) par-
ticipated and 44 (3%) declined [8]. A subset of the original study,
mothers who had both a son and a daughter 9–17 years old
(n¼350), were included in these analyses.
Participants responded to questions regarding the HPV vaccine
separately for their oldest daughter and oldest son in the 9–17
years age range. Mothers were asked whether their daughter/son
had completed the HPV vaccine series, had started (but not com-
pleted) the series, had scheduled an appointment to receive it, or
had not received any doses. Dichotomous variables were created
for initiation (Z1 dose received) and completion (Z3 doses) of
the vaccine series.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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beliefs beginning with, “If my daughter/son gets HPV,” and ending
with, “it could harm her/his future health,” “it could harm her/his
future relationship with her/his partner,” and, “I will be deva-
stated.” Response options were dichotomized with those who
reported they strongly disagreed, disagreed, or were neutral ver-
sus those who reported they agreed or strongly agreed. Mothers
also responded to the following question on a 0–100% Likert scale
with eleven points, “If your 9–17 year old daughter/son does NOT
get Gardasil, what are the chances that she/he will contract HPV?”
A similar question was asked about their child developing genitalTable 1
Demographic characteristics of families with both a son and a daughter 9–17 years
old (n¼350).
n (%)
Maternal age, years
o30 19 (5.4)
30–39 266 (76.0)
Z40 65 (18.6)
Maternal race/ethnicity
White 67 (19.1)
Black 98 (28.0)
Hispanic 178 (50.9)
Other 7 (2.0)
Maternal marital status
Single/Never married 60 (17.3)
Married/Cohabitating 189 (54.5)
Separated/Divorced/Widowed 98 (28.2)
Maternal education
Did not graduate high school 172 (49.1)
High school graduate or GED 108 (30.9)
College degree or some college 70 (20.0)
Maternal employment status
Does not work 192 (54.9)
Employed (full time or part time) 158 (45.1)
Annual household income
Less than $15,000 135 (39.0)
$15,000–$29,999 158 (45.7)
Z$30,000 53 (15.3)
Current maternal smoking 84 (24.1)
Mother ever diagnosed with an STD 55 (15.8)
Mother ever diagnosed with HPV infection 21 (6.0)
Mother ever had an abnormal pap smear 96 (27.6)
Mother ever diagnosed with atypical precancerous cervical cells/
cervical cancer
27 (7.7)
Age of daughters, mean (SD) 13.5 (2.4)
Age of sons, mean (SD) 13.1 (2.5)
Table 2
Child HPV vaccination uptake and maternal beliefs about HPV in families with both a s
Both daughters and sons %
(95% conﬁdence interval)
Neither daughters nor s
(95% conﬁdence interva
Initiated HPV vaccine 8.6 (6.0–12.0) 72.3 (67.3–76.7)
Completed HPV vaccine 2.6 (1.3–4.9) 84.3 (80.1–87.7)
HPV will harm future health 41.2 (36.1–46.5) 42.3 (37.2–47.6)
HPV will harm future
relationships
39.1 (34.1–44.4) 44.6 (39.4–50.0)
Feel devastated if child got
HPV
60.4 (55.1–65.5) 29.3 (24.7–34.4)
Positive risk of contracting
HPV
67.9 (62.6–72.7) 25.8 (21.4–30.8)
Positive risk of developing
genital warts
65.6 (60.2–70.5) 28.1 (23.5–33.2)
Want child vaccinated for
HPV in the next yearb
43.3 (37.6–49.3) 42.6 (36.9–48.5)
Feel conﬁdent they could get
child vaccinated for HPVb
44.4 (38.6–50.3) 40.1 (34.4–46.0)
a p-values calculated using McNemar's chi-squared test for paired samples.
b Mothers who answered questions about at least one child who had completed thwarts. Response options were dichotomized with those reporting
0% versus 40%. Mothers also were queried, “I want my daughter/
son vaccinated against the human papillomavirus (HPV) within
the next year,” and, “I feel conﬁdent that I could get Gardasil for
my daughter/son.” Response options were dichotomized with
those who reported they strongly disagreed, disagreed, or were
neutral versus those who reported they agreed or strongly agreed,
while mothers with one or both children having completed the
vaccine series were excluded from analysis.
McNemar's chi-squared tests for paired samples were used to
examine marginal homogeneity across children's sex in maternal
beliefs and children's HPV vaccination uptake. Statistical sig-
niﬁcance was assessed at the α¼0.05 level. All analyses were
performed using Stata Version 14.0 [9].3. Results
A total of 350 mothers indicated they had both a daughter and
a son between 9–17 years of age. Most mothers were between 30
and 39 years of age, Hispanic, and married or cohabitating
(Table 1). Mothers were more likely to report their daughters
compared to sons had initiated the series and completed it, but
overall vaccination was low, with 72.3% reporting no HPV vacci-
nation for either child (Table 2). There were no differences by
children's sex in mothers' beliefs about HPV, perceived risk of their
children contracting HPV, or perceived risk of their children
developing genital warts.
Among those who had not yet completely vaccinated either
child (n¼277), mothers were more likely to report they wanted
their daughters compared to sons vaccinated in the next year
(Table 2). Mothers were also more likely to report feeling con-
ﬁdent they could get their daughters vaccinated than their sons.4. Conclusions/discussion
In this population, HPV vaccine uptake differed by children's
sex, but maternal beliefs about HPV by children's sex were similar.
These results suggest beliefs may not be driving sex differences in
HPV vaccination. Mothers were more likely to report they wanted
their daughters vaccinated than their sons and were more likely to
report feeling conﬁdent they could get their daughters vaccinated,
despite similar perceptions of risk. Since some physicians report aon and a daughter 9–17 years old (n¼350).
ons %
l)
Daughters, but not sons %
(95% conﬁdence interval)
Sons, but not daughters %
(95% conﬁdence interval)
p-valuea
17.4 (13.8–21.8) 1.7 (0.8–3.8) o0.001
11.7 (8.7–15.5) 1.4 (0.6–3.4) o0.001
6.7 (4.5–9.9) 9.9 (7.1–13.5) 0.145
6.1 (4.0–9.2) 10.1 (7.4–13.8) 0.061
4.1 (2.4–6.8) 6.2 (4.0–9.3) 0.237
3.6 (2.1–6.3) 2.7 (1.4–5.1) 0.513
2.1 (1.0–4.4) 4.2 (2.5–7.0) 0.127
10.1 (7.1–14.3) 4.0 (2.2–7.1) 0.007
11.2 (8.0–15.5) 4.3 (2.5–7.5) 0.004
e HPV vaccine series were excluded from these analyses (n¼73 excluded).
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in getting children vaccinated by sex and provider recommenda-
tion should be further explored.
This study has several strengths and limitations. While a
strength of this study was the inclusion of a diverse, low-income
population, the small sample size limited our ability to conduct
multivariate analyses. We focused on views and behaviors that
differ by children's sex within a family, essentially controlling for
maternal characteristics, though reliance on maternal report of
children's HPV vaccination is subject to recall bias. The survey used
in this study had not been validated.
Mothers did not report different perceptions about how HPV
would impact their sons compared to daughters, yet were less
likely to vaccinate sons. This may lead to male adolescents being
exposed to vaccine-preventable strains of HPV prior to initiating
the series. Future interventions should address the disparity in
uptake by ensuring parents receive both adequate information
about HPV vaccination and equal access to the vaccine for their
sons and daughters.Disclaimer
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